Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe

M. J. Remmelink; Y. Rip; P. R. Bloemen; R. M. van den Elzen; J. R. Oddens; J. A. Nieuwenhuijzen; J. P. van der Voorn; T. G. van Leeuwen; T. M. de Reijke; D. M. de Bruin

doi:https://doi.org/10.1117/12.2670125

Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe

M. J. Remmelink, Y. Rip, P. R. Bloemen, R. M. van den Elzen, J. R. Oddens, J. A. Nieuwenhuijzen, J. P. van der Voorn, T. G. van Leeuwen, T. M. de Reijke, D. M. de Bruin

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Academic › peer-review

Abstract

Bladder cancer was the 10th most prevalent cancer worldwide in 2020.[1] Currently, the gold standard for diagnosing bladder cancer is a cystoscopy followed by a transurethral resection of the bladder tumour. The tumour invasion and grade are needed to determine the treatment plan.[2] However, a transurethral resection is an invasive procedure, needs planning and has complication risks. Therefore, finding an alternative option to determine tumour invasion and grade is necessary. That would also enable other treatment options for bladder cancer such as laser fulguration, chemo-resection and active surveillance.[3-5] Optical Coherence Tomography (OCT) has the potential to aid in the diagnosis of bladder cancer.[6-11].

Original language	English
Title of host publication	Translational Biophotonics
Subtitle of host publication	Diagnostics and Therapeutics III
Editors	Zhiwei Huang, Lothar D. Lilge
Publisher	SPIE
Volume	12627
ISBN (Electronic)	9781510664630
DOIs	https://doi.org/10.1117/12.2670125
Publication status	Published - 2023
Event	Translational Biophotonics: Diagnostics and Therapeutics III 2023 - Munich, Germany Duration: 25 Jun 2023 → 29 Jun 2023

Publication series

Name	Proceedings of SPIE - The International Society for Optical Engineering
Volume	12627

Conference

Conference	Translational Biophotonics: Diagnostics and Therapeutics III 2023
Country/Territory	Germany
City	Munich
Period	25/06/2023 → 29/06/2023

Access to Document

https://doi.org/10.1117/12.2670125

Cite this

Remmelink, M. J., Rip, Y., Bloemen, P. R., van den Elzen, R. M., Oddens, J. R., Nieuwenhuijzen, J. A., van der Voorn, J. P., van Leeuwen, T. G., de Reijke, T. M., & de Bruin, D. M. (2023). Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe. In Z. Huang, & L. D. Lilge (Eds.), Translational Biophotonics: Diagnostics and Therapeutics III (Vol. 12627). Article 126271Q (Proceedings of SPIE - The International Society for Optical Engineering; Vol. 12627). SPIE. https://doi.org/10.1117/12.2670125

Remmelink, M. J. ; Rip, Y. ; Bloemen, P. R. et al. / Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe. Translational Biophotonics: Diagnostics and Therapeutics III. editor / Zhiwei Huang ; Lothar D. Lilge. Vol. 12627 SPIE, 2023. (Proceedings of SPIE - The International Society for Optical Engineering).

@inproceedings{4cd0be28e8b9424dae92f5563d9ad341,

title = "Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe",

abstract = "Bladder cancer was the 10th most prevalent cancer worldwide in 2020.[1] Currently, the gold standard for diagnosing bladder cancer is a cystoscopy followed by a transurethral resection of the bladder tumour. The tumour invasion and grade are needed to determine the treatment plan.[2] However, a transurethral resection is an invasive procedure, needs planning and has complication risks. Therefore, finding an alternative option to determine tumour invasion and grade is necessary. That would also enable other treatment options for bladder cancer such as laser fulguration, chemo-resection and active surveillance.[3-5] Optical Coherence Tomography (OCT) has the potential to aid in the diagnosis of bladder cancer.[6-11].",

author = "Remmelink, {M. J.} and Y. Rip and Bloemen, {P. R.} and {van den Elzen}, {R. M.} and Oddens, {J. R.} and Nieuwenhuijzen, {J. A.} and {van der Voorn}, {J. P.} and {van Leeuwen}, {T. G.} and {de Reijke}, {T. M.} and {de Bruin}, {D. M.}",

year = "2023",

doi = "https://doi.org/10.1117/12.2670125",

language = "English",

volume = "12627",

series = "Proceedings of SPIE - The International Society for Optical Engineering",

publisher = "SPIE",

editor = "Zhiwei Huang and Lilge, {Lothar D.}",

booktitle = "Translational Biophotonics",

address = "United States",

}

Remmelink, MJ, Rip, Y, Bloemen, PR , van den Elzen, RM , Oddens, JR , Nieuwenhuijzen, JA , van der Voorn, JP , van Leeuwen, TG , de Reijke, TM & de Bruin, DM 2023, Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe. in Z Huang & LD Lilge (eds), Translational Biophotonics: Diagnostics and Therapeutics III. vol. 12627, 126271Q, Proceedings of SPIE - The International Society for Optical Engineering, vol. 12627, SPIE, Translational Biophotonics: Diagnostics and Therapeutics III 2023, Munich, Germany, 25/06/2023. https://doi.org/10.1117/12.2670125

Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe. / Remmelink, M. J.; Rip, Y.; Bloemen, P. R. et al.
Translational Biophotonics: Diagnostics and Therapeutics III. ed. / Zhiwei Huang; Lothar D. Lilge. Vol. 12627 SPIE, 2023. 126271Q (Proceedings of SPIE - The International Society for Optical Engineering; Vol. 12627).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Academic › peer-review

TY - GEN

T1 - Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe

AU - Remmelink, M. J.

AU - Rip, Y.

AU - Bloemen, P. R.

AU - van den Elzen, R. M.

AU - Oddens, J. R.

AU - Nieuwenhuijzen, J. A.

AU - van der Voorn, J. P.

AU - van Leeuwen, T. G.

AU - de Reijke, T. M.

AU - de Bruin, D. M.

PY - 2023

Y1 - 2023

N2 - Bladder cancer was the 10th most prevalent cancer worldwide in 2020.[1] Currently, the gold standard for diagnosing bladder cancer is a cystoscopy followed by a transurethral resection of the bladder tumour. The tumour invasion and grade are needed to determine the treatment plan.[2] However, a transurethral resection is an invasive procedure, needs planning and has complication risks. Therefore, finding an alternative option to determine tumour invasion and grade is necessary. That would also enable other treatment options for bladder cancer such as laser fulguration, chemo-resection and active surveillance.[3-5] Optical Coherence Tomography (OCT) has the potential to aid in the diagnosis of bladder cancer.[6-11].

AB - Bladder cancer was the 10th most prevalent cancer worldwide in 2020.[1] Currently, the gold standard for diagnosing bladder cancer is a cystoscopy followed by a transurethral resection of the bladder tumour. The tumour invasion and grade are needed to determine the treatment plan.[2] However, a transurethral resection is an invasive procedure, needs planning and has complication risks. Therefore, finding an alternative option to determine tumour invasion and grade is necessary. That would also enable other treatment options for bladder cancer such as laser fulguration, chemo-resection and active surveillance.[3-5] Optical Coherence Tomography (OCT) has the potential to aid in the diagnosis of bladder cancer.[6-11].

UR - http://www.scopus.com/inward/record.url?scp=85172217648&partnerID=8YFLogxK

U2 - https://doi.org/10.1117/12.2670125

DO - https://doi.org/10.1117/12.2670125

M3 - Conference contribution

VL - 12627

T3 - Proceedings of SPIE - The International Society for Optical Engineering

BT - Translational Biophotonics

A2 - Huang, Zhiwei

A2 - Lilge, Lothar D.

PB - SPIE

T2 - Translational Biophotonics: Diagnostics and Therapeutics III 2023

Y2 - 25 June 2023 through 29 June 2023

ER -

Remmelink MJ, Rip Y, Bloemen PR , van den Elzen RM , Oddens JR , Nieuwenhuijzen JA et al. Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe. In Huang Z, Lilge LD, editors, Translational Biophotonics: Diagnostics and Therapeutics III. Vol. 12627. SPIE. 2023. 126271Q. (Proceedings of SPIE - The International Society for Optical Engineering). doi: https://doi.org/10.1117/12.2670125

Ex-vivo OCT on human bladder tissue after radical cystectomy with a newly designed MEMS based forward looking OCT probe

Abstract

Publication series

Conference

Access to Document

Other files and links

Cite this